Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Metabolic Syndrome X and NCAN[original query] |
|---|
| TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nature communications 2014 5 4309. Liu Yang-Lin, Reeves Helen L, Burt Alastair D, Tiniakos Dina, McPherson Stuart, Leathart Julian B S, Allison Michael E D, Alexander Graeme J, Piguet Anne-Christine, Anty Rodolphe, Donaldson Peter, Aithal Guruprasad P, Francque Sven, Van Gaal Luc, Clement Karine, Ratziu Vlad, Dufour Jean-Francois, Day Christopher P, Daly Ann K, Anstee Quentin |
| Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits. Endocrine journal 2014 61 (7): 683-9. Kitamoto Aya, Kitamoto Takuya, Nakamura Takahiro, Ogawa Yuji, Yoneda Masato, Hyogo Hideyuki, Ochi Hidenori, Mizusawa Seiho, Ueno Takato, Nakao Kazuwa, Sekine Akihiro, Chayama Kazuaki, Nakajima Atsushi, Hotta Kiku |
| Impact of NAFLD-related SNPs on the carotid atherosclerosis development; a five-year prospective observational study. Atherosclerosis plus 2025 1 59 10-17. Hiroaki Ikezaki, Ryoko Nakashima, Yuji Matsumoto, Azusa Ohta, Sho Yamasaki, Satoshi Hiramine, Koji Takayama, Eiichi Ogawa, Masayuki Murata, Norihiro Furusyo, Jun Hayashi, Nobuyuki Shimono, Ernst J Schaef |
- Page last reviewed:Feb 1, 2024
- Content source:

